Sanford Burnham Prebys and other top US cancer centers call for urgent action to get cancer-preventing HPV vaccination back on track
(Sanford Burnham Prebys Medical Discovery Institute) Sanford Burnham Prebys has joined doctors and scientists across America at National Cancer Institute (NCI)-designated cancer centers and other organizations to issue a joint statement urging the nation's physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 20, 2021 Category: Cancer & Oncology Source Type: news
HPV Vaccination Is Lowering U.S. Cervical Cancer Rates
WEDNESDAY, May 19, 2021 -- In a finding that offers the first evidence that the human papillomavirus (HPV) vaccine is indeed protecting women from cervical cancer, new research shows cases in the United States have slowly but steadily declined over... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 19, 2021 Category: General Medicine Source Type: news
Gold leaf could help diagnose viral infections in low-resource settings
(American Chemical Society) Gold leaf -- gold metal hammered into thin sheets -- is used by artists and crafters to gild picture frames, artwork and clothing. Despite its luxurious appearance, the material is affordable and available at most craft stores. Now, researchers reporting inACS Central Science have developed gold leaf electrodes that, in combination with a CRISPR-based assay, could sensitively detect human papillomavirus (HPV) DNA in human samples. The method also could be modified to diagnose other viral infections. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 12, 2021 Category: International Medicine & Public Health Source Type: news
HPV Vaccination Rates Low for Young Adults
THURSDAY, May 6, 2021 -- Self-reported human papillomavirus (HPV) vaccination rates for young adults, whether for receipt of a dose at any age or between ages 18 and 21 years, are low, although they increased from 2010 to 2018, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 6, 2021 Category: Pharmaceuticals Source Type: news
HPV Vaccination Rates Suboptimal Within Ages 9 to 12 Years
TUESDAY, May 4, 2021 -- Despite increases since 2008, human papillomavirus (HPV) vaccination rates are suboptimal within ages 9 to 12 years, according to a study published online May 3 in Pediatrics.
Onyema Greg Chido-Amajuoyi, M.B.B.S., M.P.H.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 4, 2021 Category: Pharmaceuticals Source Type: news
Too Few Young Men Have Gotten the HPV Vaccine
FRIDAY, April 30, 2021 -- The HPV vaccine isn ' t reaching enough young American men, researchers report.
The vaccine protects against reproductive warts as well as cancers caused by human papillomavirus (HPV), the most common sexually transmitted... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 30, 2021 Category: General Medicine Source Type: news
HPV vaccination in young adults
(JAMA Network)What The Study Did:Survey data were used to estimate the rate of human papillomavirus (HPV) vaccination among young adults ages 18 to 21 in the United States. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 27, 2021 Category: Infectious Diseases Source Type: news
Mayo Clinic Q & amp;A podcast: Head and neck cancers are becoming increasingly common
There are many causes of head and neck cancers, and treatment is complicated. And one of the fastest growing demographic of cancers in the U.S. is human papillomavirus (HPV) in younger people, says Dr. Daniel Ma, a Mayo Clinic radiation oncologist. "This is a treatable disease," says Dr. Ma. "It's a disease that's very responsive [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 19, 2021 Category: Databases & Libraries Source Type: news
First patient-derived organoid model for cervical cancer
(Hubrecht Institute) Researchers from the group of Hans Clevers developed the first patient-derived organoid model for cervical cancer. They also modelled the healthy human cervix using organoids. The researchers used the platform to study sexually transmitted infections for a herpes virus. The model can potentially also be used to study human papillomavirus (HPV), which is one of the main causes of cervical cancer. The results will be published in Cell Stem Cell on the 13th of April, 2021. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 13, 2021 Category: Cancer & Oncology Source Type: news
Study identifies specific antioxidants that may reduce oncogenic HPV infection in women
(Louisiana State University Health Sciences Center) A study led by Hui-Yi Lin, Ph.D., Professor of Biostatistics, and a team of researchers at LSU Health New Orleans Schools of Public Health and Medicine has found that adequate levels of five antioxidants may reduce infection with the strains of the human papillomavirus (HPV) associated with cervical cancer development. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 12, 2021 Category: Biology Source Type: news
Routine HPV Vaccination for Older Adults May Not Be Cost-Effective
MONDAY, April 5, 2021 -- Extending the age limit for human papillomavirus (HPV) vaccination up to 45 years may not be cost-effective in the United States, according to a study published online March 11 in PLOS Medicine.
Jane J. Kim, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 5, 2021 Category: Pharmaceuticals Source Type: news
2015 to 2018 Saw Decrease in HPV Infections Among Young Women
FRIDAY, March 26, 2021 -- There have been significant declines in vaccine-type human papillomavirus (HPV) infections among both vaccinated and unvaccinated adolescent girls and young adult women, according to research published in the March 26 issue... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 26, 2021 Category: Pharmaceuticals Source Type: news
HPV Infections Are Plummeting Due to Widespread Vaccination
FRIDAY, March 26, 2021 -- Fifteen years of widespread vaccination of U.S. children with the human papillomavirus (HPV) vaccine is reaping big rewards: A more than 80% drop in new infections has been seen in women and girls under the age of 25.
That... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 26, 2021 Category: General Medicine Source Type: news
HPV vaccine has led to more than 80% drop in infections, CDC reports
Introduction of the human papillomavirus vaccine in the United States has led to a more than 80% decline in infections nationally since 2003, according to data released Thursday by the CDC. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 25, 2021 Category: Consumer Health News Source Type: news
Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018
This report describes declines in HPV vaccine-type infection prevalence among females when compared with prevalence before vaccination. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - March 25, 2021 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
